Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone administration methods in septic shock
IRCT20250730066694N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of hydrocortisone in septic shock (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Adrenal recovery according to hemodynamic, metabolic, electrolyte and inflammatory parameters. Started Sep 2025; status: completed.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on IRCT20250730066694N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250730066694N1.